FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2621207536> ?p ?o ?g. }

• W2621207536 endingPage "367" @default.
• W2621207536 startingPage "358" @default.
• W2621207536 abstract "Purpose of review Our aim was to review the rationale for the role of sodium–glucose cotransporter-2 inhibitors (SGLT-2i) as renoprotective therapy in patients with and without diabetes. Recent findings SGLT-2i are antihyperglycemic agents, approved for treating type 2 diabetes to reduce glycosylated hemoglobin, type A1c. Primary glucoregulatory effects occur through selective inhibition of SGLT-2 at the renal proximal tubule promoting glucosuria leading to blood glucose lowering. From a hemodynamic perspective, SGLT-2 inhibition is also associated with decreased glomerular hyperfiltration, an effect that is mediated through natriuresis and tubuloglomerular feedback. With renal injury and progressive nephron loss, diabetic kidney disease, and nondiabetic chronic kidney diseases share overlapping phenotypes exhibiting single nephron hyperfiltration, along with increased proteinuria. Importantly, the impact of SGLT-2 inhibition on renal and systemic hemodynamic function, including effects on lowering blood pressure, hyperfiltration, and plasma volume, are independent of blood glucose lowering and instead are because of natriuresis. Accordingly, large clinical trials with SGLT-2i investigating the potential use of SGLT-2i in patients without diabetes are now underway. Summary Based on prominent nonglycemic effects, the clinical use of SGLT-2i as renoprotective therapy may extend to nondiabetic chronic kidney diseases subtypes, which could help to address a large, unmet clinical need." @default.
• W2621207536 created "2017-06-09" @default.
• W2621207536 creator A5029467844 @default.
• W2621207536 creator A5082289947 @default.
• W2621207536 creator A5087703435 @default.
• W2621207536 date "2017-09-01" @default.
• W2621207536 modified "2023-10-13" @default.
• W2621207536 title "Do effects of sodium–glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease?" @default.
• W2621207536 cites W1969716641 @default.
• W2621207536 cites W1974115114 @default.
• W2621207536 cites W1990025047 @default.
• W2621207536 cites W2006489146 @default.
• W2621207536 cites W2016366089 @default.
• W2621207536 cites W2020861276 @default.
• W2621207536 cites W2030311010 @default.
• W2621207536 cites W2033149201 @default.
• W2621207536 cites W2033375786 @default.
• W2621207536 cites W2045668407 @default.
• W2621207536 cites W2060832805 @default.
• W2621207536 cites W2064581088 @default.
• W2621207536 cites W2069999336 @default.
• W2621207536 cites W2074850565 @default.
• W2621207536 cites W2076025908 @default.
• W2621207536 cites W2077038286 @default.
• W2621207536 cites W2089982846 @default.
• W2621207536 cites W2096494345 @default.
• W2621207536 cites W2103370616 @default.
• W2621207536 cites W2123274061 @default.
• W2621207536 cites W2123797775 @default.
• W2621207536 cites W2127833912 @default.
• W2621207536 cites W2127861507 @default.
• W2621207536 cites W2134304394 @default.
• W2621207536 cites W2140759914 @default.
• W2621207536 cites W2140785809 @default.
• W2621207536 cites W2142593697 @default.
• W2621207536 cites W2146264128 @default.
• W2621207536 cites W2148513135 @default.
• W2621207536 cites W2156587192 @default.
• W2621207536 cites W2156825907 @default.
• W2621207536 cites W2171784381 @default.
• W2621207536 cites W2175616918 @default.
• W2621207536 cites W2179831365 @default.
• W2621207536 cites W2187514862 @default.
• W2621207536 cites W2212745154 @default.
• W2621207536 cites W2218044863 @default.
• W2621207536 cites W2257723432 @default.
• W2621207536 cites W2298037886 @default.
• W2621207536 cites W2339851852 @default.
• W2621207536 cites W2418756187 @default.
• W2621207536 cites W2424539745 @default.
• W2621207536 cites W2425017047 @default.
• W2621207536 cites W2436309489 @default.
• W2621207536 cites W2492672367 @default.
• W2621207536 cites W2512006388 @default.
• W2621207536 cites W2581152894 @default.
• W2621207536 cites W4239867451 @default.
• W2621207536 doi "https://doi.org/10.1097/mnh.0000000000000343" @default.
• W2621207536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28582367" @default.
• W2621207536 hasPublicationYear "2017" @default.
• W2621207536 type Work @default.
• W2621207536 sameAs 2621207536 @default.
• W2621207536 citedByCount "23" @default.
• W2621207536 countsByYear W26212075362017 @default.
• W2621207536 countsByYear W26212075362018 @default.
• W2621207536 countsByYear W26212075362019 @default.
• W2621207536 countsByYear W26212075362020 @default.
• W2621207536 countsByYear W26212075362021 @default.
• W2621207536 countsByYear W26212075362022 @default.
• W2621207536 countsByYear W26212075362023 @default.
• W2621207536 crossrefType "journal-article" @default.
• W2621207536 hasAuthorship W2621207536A5029467844 @default.
• W2621207536 hasAuthorship W2621207536A5082289947 @default.
• W2621207536 hasAuthorship W2621207536A5087703435 @default.
• W2621207536 hasConcept C126322002 @default.
• W2621207536 hasConcept C134018914 @default.
• W2621207536 hasConcept C159641895 @default.
• W2621207536 hasConcept C174459258 @default.
• W2621207536 hasConcept C2776179406 @default.
• W2621207536 hasConcept C2777180221 @default.
• W2621207536 hasConcept C2778653478 @default.
• W2621207536 hasConcept C2779922275 @default.
• W2621207536 hasConcept C2781214132 @default.
• W2621207536 hasConcept C2781231759 @default.
• W2621207536 hasConcept C555293320 @default.
• W2621207536 hasConcept C71924100 @default.
• W2621207536 hasConcept C7643261 @default.
• W2621207536 hasConcept C84393581 @default.
• W2621207536 hasConceptScore W2621207536C126322002 @default.
• W2621207536 hasConceptScore W2621207536C134018914 @default.
• W2621207536 hasConceptScore W2621207536C159641895 @default.
• W2621207536 hasConceptScore W2621207536C174459258 @default.
• W2621207536 hasConceptScore W2621207536C2776179406 @default.
• W2621207536 hasConceptScore W2621207536C2777180221 @default.
• W2621207536 hasConceptScore W2621207536C2778653478 @default.
• W2621207536 hasConceptScore W2621207536C2779922275 @default.
• W2621207536 hasConceptScore W2621207536C2781214132 @default.
• W2621207536 hasConceptScore W2621207536C2781231759 @default.
• W2621207536 hasConceptScore W2621207536C555293320 @default.

• next